Jean Kummer NP in Annandale, Minnesota

Medical School: Sorry, her university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Jean Kummer NP is listed as: Nurse Practitioner
Credentials: NP
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 2163446303
NPI #: 1205843307
NPI Created On: 08/02/2006
NPI Last Updated Listed as: 11/09/2020
Primary Taxonomy Code: 363L00000X
License Number:
3286
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Medica Health Plans of Wisconsin
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Blood test, basic group of blood chemicals
3. Blood test, comprehensive group of blood chemicals
4. Blood test, lipids (cholesterol and triglycerides)
5. Hemoglobin a1c level
6. Blood test, thyroid stimulating hormone (tsh)
7. Hemoglobin measurement
8. Complete blood cell count (red cells, white blood cell, platelets), automated test
9. Complete blood cell count (red cells, white blood cell, platelets), automated test
10. Bacterial colony count, urine
11. Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Physician telephone patient service, 5-10 minutes of medical discussion
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Physician telephone patient service, 21-30 minutes of medical discussion
17. Administration of influenza virus vaccine
18. Administration of pneumococcal vaccine
19. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
20. Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r